OSCR

Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma.

Overview

Authors: Sofia Ramos1, Gonçalo Pereira1,2,3, Marta Martins1,4, Ana Sofia Fernandes1, Nuno Saraiva1
  1. CBIOS, ECTS, Lusófona University, Campo Grande 376, 1749-024 Lisbon, Portugal; (S.R.); (G.P.); (M.M.); (A.S.F.)
  2. Department of Biology, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal
  3. Gulbenkian Institute for Molecular Medicine (GIMM), Edifício Egas Moniz, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal
  4. Department of Biomedical Sciences, University of Alcalá, Ctra. Madrid-Barcelona Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain
Journal: Biology, volume 15, issue 14, article 1179
Dates: received 19 May 2026; accepted 14 July 2026; published online 17 July 2026
Type: Brief report · Language: English
License: CC BY
Identifiers: DOI 10.3390/biology15141179 · PMID 42510725 · PMCID PMC13405653 · OpenAlex W7169725644
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics, Connectivity
Keywords: glioma, glioblastoma, TMBIM, therapeutic target selectivity, prognosis biomarkers, biological processes
Topic: Glioma Diagnosis and Treatment (Oncology, Medicine), according to OpenAlex
Funding: Fundação para a Ciência e Tecnologia (doi.org/10.54499/UID/04567/2025, UI/BD/151424/2021); Instituto Lusófono de Investigação e Desenvolvimento (Program Seed Funding - COFAC/ILIND/CBIOS/2/2024)
Citations: not cited yet (Europe PMC); 75 references in the paper

Abstract

Gliomas are the most common and aggressive primary brain tumours, with glioblastoma (GB) exhibiting a poor prognosis and limited therapeutic response. Dysregulation of intracellular ion homeostasis, particularly Ca2+ signalling, has emerged as a key contributor to glioma progression. The transmembrane BAX inhibitor motif-containing (TMBIM) protein family regulates intracellular Ca2+ flux and cell survival; however, their role in glioma remains incompletely understood. Gene expression and clinical data from TCGA, CGGA, and Rembrandt cohorts were analysed to assess the association between TMBIM1-6 expression, tumour grade, and patient survival. Correlation analyses identified TMBIM-associated gene networks, followed by functional enrichment to characterise underlying biological processes and molecular functions. The TMBIM family members segregated into two distinct groups with opposing clinical associations. TMBIM1, TMBIM4, and TMBIM6 were upregulated and associated with poor survival, whereas TMBIM2, TMBIM3, and TMBIM5 were downregulated and associated with increased survival. Functional enrichment analyses revealed two conserved gene expression programmes: TMBIM1/4/6 are linked to membrane trafficking, metabolic and bioenergetic adaptation, while TMBIM2/3/5 are associated with cell cycle regulation and chromosomal instability. These findings uncover a previously unrecognised functional divergence within the TMBIM family in glioma. This bipartite organisation highlights TMBIM proteins as potential prognostic markers and suggests that selective targeting of specific TMBIM subgroups may improve therapeutic strategies.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The datasets containing gene correlation analysis results (PCC values and gene names) and genes included in the Venn diagrams generated for this study can be found at https://doi.org/10.5281/zenodo.19226542.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 6 keywords, 2 funders, 73 references.

Cite

This paper

Ramos, S., Pereira, G., Martins, M., Fernandes, A. S., & Saraiva, N. (2026). Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma. Biology, 15(14), 1179. https://doi.org/10.3390/biology15141179

BibTeX

@article{ramos2026transcriptomic,
author = {Ramos, Sofia and Pereira, Gonçalo and Martins, Marta and Fernandes, Ana Sofia and Saraiva, Nuno},
title = {{Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma}},
journal = {Biology},
year = {2026},
month = jul,
volume = {15},
number = {14},
pages = {1179},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2079-7737},
doi = {10.3390/biology15141179},
url = {https://doi.org/10.3390/biology15141179},
pmid = {42510725},
pmcid = {PMC13405653}
}

RIS

TY - JOUR
AU - Ramos, Sofia
AU - Pereira, Gonçalo
AU - Martins, Marta
AU - Fernandes, Ana Sofia
AU - Saraiva, Nuno
TI - Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma
T2 - Biology
J2 - Biology (Basel)
PY - 2026
DA - 2026/07/17
VL - 15
IS - 14
SP - 1179
SN - 2079-7737
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/biology15141179
UR - https://doi.org/10.3390/biology15141179
LA - en
ER -

CSL-JSON

{
"id": "10.3390/biology15141179",
"type": "article-journal",
"title": "Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma",
"container-title": "Biology",
"author": [
{
"family": "Ramos",
"given": "Sofia"
},
{
"family": "Pereira",
"given": "Gonçalo"
},
{
"family": "Martins",
"given": "Marta"
},
{
"family": "Fernandes",
"given": "Ana Sofia"
},
{
"family": "Saraiva",
"given": "Nuno"
}
],
"container-title-short": "Biology (Basel)",
"volume": "15",
"issue": "14",
"page": "1179",
"DOI": "10.3390/biology15141179",
"PMID": "42510725",
"PMCID": "PMC13405653",
"ISSN": "2079-7737",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/biology15141179",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fphys.2025.1733266 [code]
The ion transport, GPCR, and RTK toolkit expression in the human cerebrovascular endothelial cell line, hCMEC/D3: an Omics perspective.
Journal: Frontiers in physiology
In common: genetics / omics, 3 references
[2] doi:10.1038/s41598-025-97333-4
Identification and validation of LY6H and GRM3 as candidate biomarkers for Glioma-related epilepsy.
Journal: Scientific reports
In common: clinical / translational, genetics / omics, other condition, 3 references
[3] doi:10.1093/neuonc/noag059
Combined patch-clamp electrophysiology and single-cell genomic analysis reveal spiking tumor cells at the neocortical glioblastoma interface in humans.
Journal: Neuro-oncology
In common: genetics / omics, other condition, 3 references
[4] doi:10.1038/s41591-024-03224-y [code]
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity.
Journal: Nature medicine
In common: clinical / translational, other condition, 3 references
[5] doi:10.3390/cancers18132092
TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activated Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study.
Journal: Cancers
In common: genetics / omics, other condition, 3 references
[6] doi:10.3389/fimmu.2022.1018942
Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes.
Journal: Frontiers in immunology
In common: clinical / translational, other condition, 3 references
[7] doi:10.1007/s12672-025-03604-x
Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines.
Journal: Discover oncology
In common: other condition, 3 references
[8] doi:10.1186/s40478-023-01613-x
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis.
Journal: Acta neuropathologica communications
In common: genetics / omics, other condition, 3 references
[9] doi:10.1016/j.celrep.2024.115149 [code]
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.
Journal: Cell reports
In common: other condition, 3 references
[10] doi:10.3389/fonc.2022.889351
Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma.
Journal: Frontiers in oncology
In common: clinical / translational, genetics / omics, other condition, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.